Aceragen Performance

ACGNDelisted Stock   0.75  0.23  23.47%   
The firm shows a Beta (market volatility) of 1.37, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aceragen will likely underperform. Aceragen right now shows a risk of 0.0%. Please confirm Aceragen jensen alpha and the relationship between the value at risk and day typical price , to decide if Aceragen will be following its price patterns.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aceragen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Aceragen is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Begin Period Cash Flow32.5 M
  

Aceragen Relative Risk vs. Return Landscape

If you would invest  75.00  in Aceragen on September 3, 2024 and sell it today you would earn a total of  0.00  from holding Aceragen or generate 0.0% return on investment over 90 days. Aceragen is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Aceragen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Aceragen Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Aceragen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aceragen, and traders can use it to determine the average amount a Aceragen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ACGN
Based on monthly moving average Aceragen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aceragen by adding Aceragen to a well-diversified portfolio.

Aceragen Fundamentals Growth

Aceragen Stock prices reflect investors' perceptions of the future prospects and financial health of Aceragen, and Aceragen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aceragen Stock performance.

About Aceragen Performance

By examining Aceragen's fundamental ratios, stakeholders can obtain critical insights into Aceragen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Aceragen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.

Things to note about Aceragen performance evaluation

Checking the ongoing alerts about Aceragen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aceragen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Aceragen is not yet fully synchronised with the market data
Aceragen has some characteristics of a very speculative penny stock
Aceragen has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 4.86 M. Net Loss for the year was (23.36 M) with profit before overhead, payroll, taxes, and interest of 0.
Aceragen generates negative cash flow from operations
Evaluating Aceragen's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Aceragen's stock performance include:
  • Analyzing Aceragen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aceragen's stock is overvalued or undervalued compared to its peers.
  • Examining Aceragen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Aceragen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aceragen's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Aceragen's stock. These opinions can provide insight into Aceragen's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Aceragen's stock performance is not an exact science, and many factors can impact Aceragen's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in Aceragen Stock

If you are still planning to invest in Aceragen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aceragen's history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope